NYU Langone United States

Ms Maria  Brillant
Ms Maria Brillant
Sr. Director, Advanced Practice Nurses 

NYU Langone Medical Center United States

NYU Langone Medical Center is one of the nation’s premier academic medical centers. Our trifold mission to serve, teach, and discover is achieved daily through an integrated academic culture devoted to excellence in patient care, education, and research.

Located in the heart of Manhattan, with additional facilities throughout the New York City area, NYU Langone consists of four hospitals:

Professor Didier Loulmet
Director, Robotic Cardiac Surgery, Tisch Hospital - Chief Cardiac Surgery at NYULMC 

NYU Langone Medical Center United States

Dr Claude Chemtob
Professor, Department of Psychiatry;Professor, Department of Child and Adolescent Psychiatry  

NYU Langone Medical Center United States

NYU Langone Medical Center is one of the nation’s premier academic medical centers. Our trifold mission to serve, teach, and discover is achieved daily through an integrated academic culture devoted to excellence in patient care, education, and research.

Located in the heart of Manhattan, with additional facilities throughout the New York City area, NYU Langone consists of four hospitals:

Dr Louai Razzouk
Physician 

NYU Langone Medical Center United States

NYU Langone Medical Center is one of the nation’s premier academic medical centers. Our trifold mission to serve, teach, and discover is achieved daily through an integrated academic culture devoted to excellence in patient care, education, and research.Located in the heart of Manhattan, with additional facilities throughout the New York City area, NYU Langone consists of four hospitals:

Ms Betsy Farrell
Facilities Manager, Research/Education Portfolios 

NYU Langone Medical Center United States

Dr Judith Schipper
Coordinator HF Program 

NYU Langone Medical Center United States

Miss Karen Tan
NP 

NYU Langone Medical Center- Hospital for Joint Diseases United States

The Department of Orthopaedic Surgery is responsible for providing the full range of adult orthopaedic services to patients at the Hospital for Joint Diseases at NYU Langone Medical Center.

This specialty hospital is dedicated solely to the treatment of orthopaedic and rheumatologic conditions. Members of the Hospital for Joint Diseases service follow the highest professional standards in evaluating and treating in-hospital patients, patients who seek treatment in the numerous clinics, and patients who visit the Hospital's Immediate Care Center, a unique facility that provides urgent orthopaedic care.

Renat Sukhov
Pediatric Rehabilitation Associate Professor MD 

NYU School of Medicine United States

Specialties:  Oncology, Cancer Research, Cell Biology

NYU School of Medicine is one of the nation’s preeminent academic institutions. For more than 150 years, we have trained thousands of physician-scientists who have helped to shape the course of medical history and enrich the lives of countless people. Through medical education, scientific research, and patient care, we continue to demonstrate our deep, abiding commitment to improving the human condition.

The percentage of NYU graduates who are members of medical school faculties is among the highest in the nation. For most of them, an invaluable part of that training was their service at Bellevue Hospital, one of the nation’s finest municipal hospitals, where NYU physicians have provided clinical and emergency care to
New York City’s poor and immigrant populations for more than a century.

As part of a “biomedical corridor” extending from 23rd to 34th Streets along Manhattan’s East River Drive, our institution is guided by the promise of “translational medicine,” in which scientific discoveries are urgently translated into innovative treatments for patients. To create an environment worthy of rapid medical advances, we are constructing new research and clinical facilities. These state-of-the-art facilities will serve as the home for our physician-scientists who are the intellectual foundation of the School. In addition, we are recruiting a new generation of scholars and teachers who have established national and international reputations. And we are admitting some of the nation’s best and brightest students, many of whom will become tomorrow’s leaders in the medical profession.

Your focus and ours is whether NYU is the right place to pursue your medical education. We hope that this website captures the spirit of the educational enterprise at NYU, as well as the experience of studying medicine in the heart of New York City.

Professor Leslie I Gold
Oncology, Cancer Research, Cell Biology 

NYU School of Medicine United States

CARDIOVASCULAR

Dr. Mignatti's two NIH grants support the study of a novel mechanism that controls the growth of a number of cells including the cells of the blood vessels. These cells produce a protein referred to as Membrane Type 1 Matrix Metalloproteinase (MT1-MMP). MT1-MMP has the capacity of digesting structural proteins that surround the cells, an important function for new vessels to make their way into the tissues that need to be vascularized. Unlike proteins with similar functions, MT1-MMP is bound to the cell membrane, the sheath that surrounds the cell, a feature that makes it similar to other proteins - growth factor- or hormone- receptors. These proteins have the role of relaying signals from the outside to the inside of the cell when they bind their cognate growth factors or hormones. These signals regulate many cell functions, including the capacity to grow and form new vessels. MT1-MMP also binds an extracellular protein called tissue inhibitor of metalloproteinases-2 (TIMP-2). Dr. Mignatti's group discovered that MT1-MMP binding of TIMP-2 activates signals inside the cell which stimulate cell growth and movement. The current work aims to understand the mechanisms by which MT1-MMP relays signals from the outside to the inside of the cell. For this purpose the research group uses both techniques of molecular and cellular biology, and animal models engineered in the laboratory. The results of these studies can afford the development of novel drugs to control the growth of a variety of cells including those that form blood vessel.

Mr Paolo Mignatti
Faculty